MARA LEE BEEBE: Open Payments
NPI 1033782099 · SPRING HILL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,937 in 201 payments from 19 companies in 2025. Trend: 2023 $1,920 · 2024 $2,790 · 2025 $3,937
Food & beverage: $3,898Education: $40
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 78 | $1,421 |
| PFIZER INC. | 18 | $388 |
| Ardelyx, Inc. | 24 | $325 |
| Madrigal Pharmaceuticals | 11 | $322 |
| GENZYME CORPORATION | 8 | $296 |
| Phathom Pharmaceuticals, Inc. | 12 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $180 |
| Janssen Biotech, Inc. | 7 | $154 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $141 |
| Celltrion USA Inc. | 4 | $106 |
Products named: RINVOQ, DUPIXENT, SKYRIZI, IBSRELA, REZDIFFRA, LINZESS, VOQUEZNA, XELJANZ.
Industry payments across FL — which companies pay providers there.
